• Questcor Pharmaceuticals Inc., of Anaheim, Calif., said its initial commercialization plans for rheumatology drug H.P. Acthar Gel (repository corticotropin injection) include the creation of a 12-member sales force, plus a national sales director and two regional sales managers.